{
    "code": "02019997",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02019997",
    "time": "2018-08-31 03:45:44",
    "許可證字號": "衛署藥輸字第019997號",
    "註銷狀態": "已註銷",
    "註銷日期": "105\/08\/19",
    "註銷理由": "自請註銷",
    "有效日期": "107\/07\/10",
    "發證日期": "82\/07\/10",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00201999704",
    "中文品名": "樂酸克靜脈點滴輸注用凍晶注射劑４０公絲",
    "英文品名": "LOSEC 40MG I.V. INFUSION",
    "適應症": "下列病症無法以口服藥物有效治療時之取代療法：　　　　　　　　　　　　十二指腸潰瘍、胃潰瘍、逆流性食道炎及ＺＯＬＬＩＮＧＥＲ－　　　　　　ＥＬＬＩＳＯＮ症。",
    "劑型": "243凍晶注射劑",
    "包裝": "瓶裝",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "主成分略述": [
        "OMEPRAZOLE"
    ],
    "限制項目": "02輸　入",
    "申請商名稱": "1434901100  臺灣阿斯特捷利康股份有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "F420022000  ASTRAZENECA AB",
        "製造廠廠址": "S-151 85 SODERTALJE  SWEDEN",
        "製造廠公司地址": ""
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "5640002300",
            "成分名稱": "OMEPRAZOLE",
            "含量描述": "",
            "含量": "40.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "中文仿單___20120223.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02019997&Seq=032&Type=9"
        }
    ]
}